FISCHERFischer Medical Ventures Ltd.

    Fischer Medical Ventures Q2 FY27 Results: Consolidated Net Profit ₹0.80 Crore on Total Income of ₹112 Crore

    • Earnings
    • medical devices and healthcare

    Fischer Medical Ventures (NSE: FISCHER) reported consolidated total income of ₹112.02 crore and net profit of ₹80.45 lakh for the quarter ended 30 Sep 2026. Standalone total income was ₹30.65 crore and net profit ₹20.58 crore, it said in a filing on 14 Nov 2026.

    Key highlights

    Consolidated

    Including its subsidiaries

    • Total income: ₹112.02 crore, up 26.2% YoY and 34.3% QoQ
    • Net profit and EPS: ₹80.45 lakh, down 94.2% YoY; basic EPS ₹0.01 against ₹2.15
    • Finance costs: ₹3.43 crore, up 273.3% YoY
    • Revenue from operations: ₹107.44 crore, up 24.5% YoY

    Standalone

    The company on its own, without its subsidiaries

    • Total income: ₹30.65 crore, up 245.9% YoY; other income ₹30.38 crore
    • Net profit and EPS: ₹20.58 crore; basic EPS ₹0.31 against ₹0.13
    • Revenue from operations: ₹0.28 crore, down 96.3% YoY
    • Finance costs: ₹1.29 crore, up 15.1% YoY

    Summary

    Consolidated ₹ crore
    ParticularsQ2 FY27Q2 FY26YoYQ1 FY27QoQ
    112.0288.78+26.2%83.40+34.3%
    0.8013.85-94.2%3.79-78.8%
    EPS, basic (₹)0.012.15-99.5%0.06-83.3%

    Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

    Consolidated total income rose 26.2% YoY, but net profit fell 94.2% to ₹80.45 lakh. Revenue from operations of ₹107.44 crore made up 95.9% of total income, so the sales line carries most of the top-line growth, while other income of ₹4.58 crore is 4.1% of total income.

    Profit before tax of ₹8.75 crore fell 49.1% YoY, so the gap between pre-tax profit and net profit is wider than a year earlier. Net profit fell by a larger percentage than profit before tax, and the year-ago base of ₹13.85 crore was itself stated after a revision to comparatives for certain foreign subsidiaries, which the auditor flagged as an emphasis of matter. The company says the revisions do not affect the group's overall annual profit or loss or closing reserves for the previous financial year.

    Finance costs of ₹3.43 crore are up 273.3% YoY, though they were broadly flat against the previous quarter at ₹3.54 crore. Against the quarter before, net profit fell 78.8% from ₹3.79 crore while total income rose 34.3%.

    Standalone ₹ crore
    ParticularsQ2 FY27Q2 FY26YoYQ1 FY27QoQ
    30.658.86+245.9%1.61n/a
    20.580.84n/a-3.50n/a
    EPS, basic (₹)0.310.13+138.5%-0.05n/a

    Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

    Standalone total income of ₹30.65 crore is mostly other income: ₹30.38 crore, or 99.1% of the total. Revenue from operations fell to ₹0.28 crore from ₹7.43 crore a year earlier, so the standalone result this quarter rests almost entirely on other income.

    Standalone profit before tax of ₹26.08 crore and net profit of ₹20.58 crore compare with ₹1.38 crore and ₹0.84 crore a year earlier. The standalone half-year cash flow statement shows dividend income of ₹27.05 crore as an adjustment line, and the standalone other income for the quarter is ₹30.38 crore.

    Inference

    The filing reports share capital proceeds of ₹77.52 crore in the half year from conversion of convertible warrants, with allotments made between 11 Aug 2026 and 17 Aug 2026 at ₹23.40 a share. The statement shows paid-up equity share capital of ₹69.87 crore at 30 Sep 2026. Note 4 records a sub-division of the share of ₹10 into ten shares of Re 1 each, with EPS restated for comparative periods.

    The filing declares no dividend. It does not give a reason for the rise in consolidated total income or in purchases of traded goods, nor for the standalone other income, so whether that other income will recur is not known.

    Filed with BSE on . Reference: Original filing (PDF)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Latest posts